Phenindamine
- Level
- Commodity
- Parent
- 51313400
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313412This classification denotes a histamine-1 receptor antagonist with the molecular formula C19H19N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 772BQ8KSST, chemically known as 2,3,4,9-tetrahydro-2-methyl-9-phenyl-lh-indeno(2,1-c)pyridine but generally known as phenindamine, which bears US NIH Compound Identifier 11291. European Medicines Agency schedules Phenindamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09764MIG. The term PHENINDAMINE is an International Non-Proprietary Name. World Health Organization schedules phenindamine in its Anatomical Therapeutic Chemical (ATC) Classification. PHENINDAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule phenindamine under HS 29339920 and SITC 51577. As of Q4 2014, PHENINDAMINE remains the US FDA Preferred Term for this commodity. Phenindamine bears US NLM identifiers UMLS ID C0070563 and NCI Concept Code C87745. SMILES: N1(CC2=C(CC1)C1C(C2C2CCCCC2)CCCC1)C.
Same parent
Under 51313400 · 41Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.